Fred K Fioravanti, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 112 Marwood Rd, #5000, Cabot, PA 16023 Phone: 724-352-4448 Fax: 724-352-4412 |
Cheryl Ann Thompson, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 112 Marwood Rd, #5000, Cabot, PA 16023 Phone: 724-352-4448 Fax: 724-352-4412 |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted EYLEA (aflibercept) Injection Breakthrough Therapy designation for the treatment of diabetic retinopathy in patients with diabetic macular edema (DME).
An irregularity within many neuroblastoma cells may indicate whether a neuroblastoma tumor, a difficult-to-treat, early childhood cancer, is vulnerable to a new class of anti-cancer drugs known as BET bromodomain inhibitors, Dana-Farber/Children's Hospital Cancer Center scientists will report at the annual meeting of the American Association for Cancer Research in Washington, April 6-10.
There is little argument among experts that autism spectrum disorders (ASD), complex developmental disabilities that vary widely in their severity, are caused by both genetic and environmental factors. Advances in genome sequencing now permit scientists to uncover specific mutations in DNA that are associated with ASD at unprecedented resolution. Such data are vital to understanding the genetic basis of the disorder.
Several drugmakers have reached an agreement "to supply up to 200 million doses a year of cut-price pneumococcal vaccines to developing nations," according to GAVI Alliance, Reuters reports.
› Verified 2 days ago